490 related articles for article (PubMed ID: 29472855)
21. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.
Cuajungco MP; Goldstein LE; Nunomura A; Smith MA; Lim JT; Atwood CS; Huang X; Farrag YW; Perry G; Bush AI
J Biol Chem; 2000 Jun; 275(26):19439-42. PubMed ID: 10801774
[TBL] [Abstract][Full Text] [Related]
22. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.
House E; Collingwood J; Khan A; Korchazkina O; Berthon G; Exley C
J Alzheimers Dis; 2004 Jun; 6(3):291-301. PubMed ID: 15201484
[TBL] [Abstract][Full Text] [Related]
23. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
24. Copper, iron and zinc in Alzheimer's disease senile plaques.
Lovell MA; Robertson JD; Teesdale WJ; Campbell JL; Markesbery WR
J Neurol Sci; 1998 Jun; 158(1):47-52. PubMed ID: 9667777
[TBL] [Abstract][Full Text] [Related]
25. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
26. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
[TBL] [Abstract][Full Text] [Related]
27. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
28. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
29. Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
Kim N; Lee HJ
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299316
[TBL] [Abstract][Full Text] [Related]
30. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
31. Bifunctional backbone modified squaramide dipeptides as amyloid beta (Aβ) aggregation inhibitors.
Dattatray Shinde S; Kumar Behera S; Kulkarni N; Dewangan B; Sahu B
Bioorg Med Chem; 2024 Jan; 97():117538. PubMed ID: 38056379
[TBL] [Abstract][Full Text] [Related]
32. Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy.
Solovyev N; El-Khatib AH; Costas-Rodríguez M; Schwab K; Griffin E; Raab A; Platt B; Theuring F; Vogl J; Vanhaecke F
J Biol Chem; 2021; 296():100292. PubMed ID: 33453282
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Summers KL; Roseman G; Schilling KM; Dolgova NV; Pushie MJ; Sokaras D; Kroll T; Harris HH; Millhauser GL; Pickering IJ; George GN
Inorg Chem; 2022 Sep; 61(37):14626-14640. PubMed ID: 36073854
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
Price KA; Crouch PJ; White AR
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
[TBL] [Abstract][Full Text] [Related]
35. Interactions of metals and Apolipoprotein E in Alzheimer's disease.
Xu H; Finkelstein DI; Adlard PA
Front Aging Neurosci; 2014; 6():121. PubMed ID: 24971061
[TBL] [Abstract][Full Text] [Related]
36. Biometals as Potential Predictors of the Neurodegenerative Decline in Alzheimer's Disease.
Lavado LK; Zhang MH; Patel K; Khan S; Patel UK
Cureus; 2019 Sep; 11(9):e5573. PubMed ID: 31695992
[TBL] [Abstract][Full Text] [Related]
37. Effect of metal ions on Alzheimer's disease.
Liu F; Zhang Z; Zhang L; Meng RN; Gao J; Jin M; Li M; Wang XP
Brain Behav; 2022 Mar; 12(3):e2527. PubMed ID: 35212185
[TBL] [Abstract][Full Text] [Related]
38. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
[TBL] [Abstract][Full Text] [Related]
39. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.
Wang D; Zhang Q; Hu X; Wang W; Zhu X; Yuan Z
Acta Biomater; 2018 Jan; 65():327-338. PubMed ID: 29111371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
